Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RFC5 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
mRNA | WDR33 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | PRKX | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | PHF14 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
mRNA | GPHN | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
mRNA | HECTD4 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | SUPT16H | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
mRNA | MBD3 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
mRNA | SLAIN1 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
mRNA | SF1 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |